Her Estrogen Patches Are Out of Stock, and Her Part D Plan Won’t Cover the Replacement. She Faces the Full Cash Price Until an Exception Is Approved

Published November 10, 2026, 6:02am ET · 4 min read

The Full Benefits Desk desk. Editor: Gerelyn Terzo.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A concerned older woman with short blonde hair and red glasses stands in a pharmacy, speaking to a blurred pharmacist. She wears a blue and white striped shirt under a textured brown knitted cardigan, and her right hand is raised to her temple. The pharmacist, seen from behind, is holding a white box. In the background, out-of-focus pharmacy shelves display various health products.
An older woman expresses concern or confusion at a pharmacy, reflecting the challenges beneficiaries may face with 2027 Medicare plan changes and new prior authorization requirements. © Gligatron / Getty Images

Imagine a 67-year-old woman tries to refill her estradiol patches and hears the same answer for the third week running: out of stock. Her doctor prescribes an estrogen cream instead. But her Part D plan doesn’t cover it, leaving her facing the full retail price. None of that spending counts toward Medicare’s annual drug cap.

More women are landing in her spot. Reuters reported on October 28 that shortages have spread beyond estrogen patches as patients seek other hormone formulations. In September, the FDA said it was working with all six manufacturers of estradiol patches to raise supply, even though it had not formally designated the patches as in shortage. Women have been pharmacy-hopping, cutting doses and changing brands. For women sent home empty-handed, finding another medication is only half the problem. They also need to know whether Medicare will pay for it.

Same Hormone, Different Coverage

Part D formularies list specific products down to the dose. The exact formulation, drug name, strength and prescribed indication decide whether a replacement is covered and how much she pays. A patch, a gel, a cream and an injection can all deliver estradiol, yet one plan may put one on a cheap tier, push another to an expensive tier, attach prior authorization to a third and leave a fourth off the list entirely.

Before taking a substitute, she should ask the pharmacist. The pharmacist can run the prescription through her plan and identify the problem: a drug that’s not covered, prior authorization, a quantity limit or a high copay. Each problem has a different fix.

When the Replacement Is Not on the List

She should look for a covered option first. Another patch brand or strength, or a covered gel, may work medically and cost her only a standard copay. A full-price prescription should be the last resort.

If her doctor decides the covered options won’t work, she can request a formulary exception. Her prescriber must explain why the covered alternatives wouldn’t work for her or could cause harm. Plans generally must decide within 72 hours, or within 24 hours if the prescriber says waiting could seriously harm her health. Approval is never guaranteed, and she can appeal a denial. If the substitute is covered but sits on an expensive tier, she may also qualify for a tiering exception to lower her cost.

What the 2027 Drug Cap Does and Does Not Cover

Part D caps out-of-pocket spending on covered drugs at $2,100 in 2026, rising to $2,400 in 2027. The cap applies to covered Part D drugs. What she pays for a drug her plan excludes generally doesn’t count unless the plan approves an exception. That leads to a problem: a woman who already hit the 2026 cap on other medications still pays full retail for an off-formulary cream every month.

An approved exception moves the drug inside the cap. Her payments start counting, and if she has already reached the cap, she pays $0 for covered drugs for the rest of the year. For a widow living on a monthly Social Security check, the extra cost comes straight out of her budget.

Timing matters right now. Open enrollment runs through December 7. Exceptions generally last through the end of the plan year, so switching to a new plan for 2027 can mean filing a new request, though a 2027 plan that already lists her substitute could make the exception unnecessary.

Empty Pharmacy Shelves Can Outlast an Approval

Insurance approval and physical supply are separate problems. An approved exception does nothing if no nearby pharmacy has the drug. Before she switches, she should call several in-network pharmacies, including her plan’s mail-order pharmacy, and confirm they have the exact strength in stock. An out-of-network pharmacy may leave her paying full price unless her plan allows an exception. The FDA said availability of specific brands may vary by pharmacy or location. So a different covered brand or strength of her original patch may be on a shelf across town.

What to Do Before Switching Medication

  1. Line up the prescriber, pharmacy and plan before changing anything. Get the exact rejection reason from the pharmacy. Then call the number on her plan card to confirm which estrogen products, strengths and forms the plan covers, and ask her prescriber whether any of them would work.
  2. File the exception with a strong prescriber statement. If no covered option works, her doctor should submit the formulary exception with a written medical reason. The doctor should request the 24-hour expedited review if a gap in therapy would seriously harm her health.
  3. Check 2027 plans before December 7. Enter the exact substitute, with strength and form, into Medicare’s Plan Finder. If her current plan leaves it off its 2027 drug list and a competing plan covers it, switching puts the drug under the $2,400 cap starting January 1 without requiring an exception.

Contact [email protected] for any questions or corrections.

Gerelyn Terzo

Gerelyn Terzo is the author of dividend investing handbook "Dividend Investing Strategies: How to Have Your Cake & Eat It Too." A veteran financial journalist, she covers agri-finance for outlets like Global AgInvesting and the broader stock market and personal finance for 24/7 Wall Street. She began at CNBC and later helped launch Fox Business in New York. Gerelyn currently resides in Woodland Park, Colorado and dabbles in nature photography as a hobby.

All articles →